Concepedia

Jérôme-Maurice Dobrowolski

JD

2

Publications

67

Citations

2

H-Index

2019

Active since

Affiliations

MaxCyte (United States)(Current)

Jérôme-Maurice Dobrowolski is an author at MaxCyte (United States) specializing in crispr, cellular therapies, and genome editing.

ORCID

Top concepts

Publications per year

2019–2022

2

Publications

2

Preclinical Evaluation of CRISPR-Edited CAR-NK-92 Cells for Off-the-Shelf Treatment of AML and B-ALL

Guillermo Ureña-Bailén, Jérôme-Maurice Dobrowolski, Yujuan Hou et al. · International Journal of Molecular Sciences · 2022 · 47 citations · Full text

, , +18

Persistent Basophilia May Suggest an “Accelerated Phase” in the Evolution of CALR-Positive Primary Myelofibrosis Toward Acute Myeloid Leukemia

Jérôme-Maurice Dobrowolski, Sergiu Paşca, Patric Teodorescu et al. · Frontiers in Oncology · 2019 · 20 citations · Full text

Rows per page

1–2 of 2